L
Lyell Immunopharma, Inc.
LYEL · NASDAQ · Healthcare · 342M
Closing price
$8.71
-0.91% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.6×
Enterprise value / EBITDAEV/EBITDA
-0.5×
Free cash flow yieldFCF yield
-101.3%
Return on equityROE
-110.6%
Operating margin
-566038.9%
Net debt / EBITDAbalance-sheet strength
0.0×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.